查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1908730

生醫材料市場規模、佔有率和趨勢分析報告：按產品、應用、地區和細分市場預測，2026-2033年

Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生醫材料市場概述

2025年全球生醫材料市場規模估計為2,369.9億美元，預計2033年將達到8,365.4億美元。

預計從 2026 年到 2033 年，該市場將以 17.25% 的複合年成長率成長。肌肉骨骼疾病和慢性骨骼疾病發生率的增加預計將推動對生醫材料植入的需求，並促進市場擴張。

先進外科技術的傳播

全球微創和先進外科手術的普及是推動生醫材料需求成長的主要因素。醫療機構擴大採用微創技術，因為這些技術能夠縮短住院時間、減少術後併發症並加速患者復健。這些手術需要高度專業的生醫材料，這些材料必須輕質、堅固、具有生物相容性，並且通常具有生物可吸收性。因此，整形外科、心血管外科和普通外科領域對先進聚合物、複合材料和生物活性材料的需求正在穩步成長。

機器人輔助手術、影像引導治療和導管介入手術的日益普及，進一步推動了對具有卓越機械和生物學性能的精密工程生醫材料的需求。用於這些手術的生醫材料必須具備更高的柔軟性、可控的分解性和良好的組織結合力，以確保安全性和長期功能。這推動了生物可吸收支架、微創整形外科植入和軟組織支架的創新，使外科醫生能夠實現更高的手術精確度並改善患者的治療效果。

此外，意識提升、醫療服務覆蓋範圍的擴大以及慢性病患病率的上升等因素也促進了先進外科手術方案的普及。微創手術因其長期成本效益而備受青睞，因為它能降低復原成本和再次手術率。外科手術實踐的這些結構性變化正在推動對高性能生醫材料的持續需求，使其成為全球生醫材料產業的關鍵成長引擎。

目錄

第1章調查方法和範圍

第2章生醫材料市場：執行摘要

  • 市場概覽
  • 細分市場概覽
  • 競爭格局概述

第3章生醫材料市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 生醫材料市場分析工具
    • 產業分析：波特五力模型
    • PESTLE分析

第4章生醫材料市場：依產品分類的估算與趨勢分析

  • 全球生醫材料市場：按產品分類的波動分析
  • 全球生醫材料市場規模及產品趨勢分析（2021-2033年）
    • 金屬
    • 自然的
    • 陶瓷製品
    • 聚合物

第5章生醫材料市場：按應用分類的估算與趨勢分析

  • 全球生醫材料市場：按應用領域分類的變化分析
  • 全球生醫材料市場規模及應用趨勢分析（2021-2033年）
    • 心血管系統
    • 眼科
    • 牙科
    • 整形外科
    • 創傷治療
    • 組織工程
    • 整形外科
    • 神經
    • 其他

第6章：區域商業分析

  • 2025年及2033年區域市佔率分析
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 對主要市場參與企業近期趨勢和影響的分析
  • 全球市場分析
  • 公司/競爭對手分類
    • Medtronic
    • Evonik Industries AG
    • Carpenter Technology Corporation
    • Berkeley Advanced Biomaterials
    • Invibio Ltd
    • Zimmer Biomet Holdings, Inc.
    • BASF SE
    • Covalon Technologies Ltd
    • Stryker
    • Johnson & Johnson
    • Dentsply Sirona
    • CoorsTek Inc
    • Corbion
    • Regenity Biosciences
Product Code: GVR-2-68038-637-0

Biomaterials Market Summary

The global biomaterials market size was estimated at USD 236.99 billion in 2025 and is projected to reach USD 836.54 billion by 2033, growing at a CAGR of 17.25% from 2026 to 2033. The growing incidence of musculoskeletal and chronic skeletal medical conditions is expected to stimulate the demand for implants based on biomaterials, thereby enhancing market expansion.

Rise of Advanced Surgical Procedures

The global shift toward minimally invasive and technologically advanced surgical procedures is a major driver accelerating demand for biomaterials. Healthcare providers are increasingly adopting minimally invasive techniques due to their ability to reduce hospital stays, lower post-operative complications, and improve patient recovery timelines. These procedures require highly specialized biomaterials that are lightweight, high-strength, biocompatible, and often bioresorbable. As a result, demand for advanced polymers, composites, and bioactive materials is rising steadily across orthopedic, cardiovascular, and general surgical applications.

The growing use of robotic-assisted surgery, image-guided interventions, and catheter-based procedures is further strengthening the need for precision-engineered biomaterials with superior mechanical and biological performance. Biomaterials used in these procedures must offer enhanced flexibility, controlled degradation, and strong tissue interaction to ensure safety and long-term functionality. This is driving innovations in bioresorbable stents, minimally invasive orthopedic implants, and soft tissue scaffolds, enabling surgeons to achieve better procedural accuracy and improved patient outcomes.

In addition, increasing patient awareness, rising healthcare accessibility, and the growing burden of chronic diseases are contributing to the widespread adoption of advanced surgical solutions. Minimally invasive procedures are being favored for their cost-effectiveness over the long term, as they reduce rehabilitation expenses and revision surgery rates. This structural shift in surgical practice is reinforcing sustained demand for high-performance biomaterials, making it a critical growth engine for the global biomaterials industry.

Global Biomaterials Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global biomaterials market report on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Metallic
  • Natural
  • Ceramics
  • Polymers
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiovascular
    • Sensors
    • Stents
    • Guidewires
    • Implantable Cardiac Defibrillators
    • Pacemakers
    • Vascular Grafts
    • Others
  • Ophthalmology
    • Synthetic Corneas
    • Intraocular Lens
    • Contact Lens
    • Ocular Tissue Replacement
    • Others
  • Dental
    • Tissue Regeneration Materials
    • Dental Implants
    • Bone Grafts & Substitutes
    • Dental Membranes
    • Others
  • Orthopedics
    • Joint Replacement biomaterials
    • Orthobiologics
    • Bioresorbable Tissue Fixation Products
    • Viscosupplementation
    • Spine Biomaterials
    • Others
  • Wound Healing
    • Fracture Healing Device
    • Adhesion Barrier
    • Skin Substitutes
    • Internal Tissue Sealant
    • Surgical Hemostats
    • Others
  • Tissue Engineering
  • Plastic Surgery
    • Facial Wrinkle Treatment
    • Soft Tissue Fillers
    • Craniofacial Surgery
    • Bioengineered Skins
    • Peripheral Nerve Repair
    • Acellular Dermal Matrices
    • Others
  • Neurology
    • Neural Stem Cell Encapsulation
    • Shunting Systems
    • Hydrogel Scaffold For CNS Repair
    • Cortical Neural Prosthetics
    • Others
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation And Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List Of Primary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Biomaterials Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Biomaterials Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising Demand As A Consequence Of Accidental Injuries & Chronic Conditions
      • 3.3.1.2. Advances In Biomaterials Technologies
      • 3.3.1.3. Expansion In The Usage Scope Of Biomaterials
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Expense Associated With The Development Of Biomaterials
      • 3.3.2.2. Problems Related To Biocompatibility Of Biomaterials
  • 3.4. Biomaterials Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTLE Analysis

Chapter 4. Biomaterials: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Biomaterials Market Product Movement Analysis
  • 4.3. Global Biomaterials Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 4.3.1. Metallic
      • 4.3.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 4.3.2. Natural
      • 4.3.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 4.3.3. Ceramics
      • 4.3.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 4.3.4. Polymers
      • 4.3.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)

Chapter 5. Biomaterials: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Biomaterials Market Application Movement Analysis
  • 5.3. Global Biomaterials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 5.3.1. Cardiovascular
      • 5.3.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.1.1.1. Sensors
          • 5.3.1.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.1.1.2. Stents
          • 5.3.1.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.1.1.3. Guidewires
          • 5.3.1.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.1.1.4. Implantable Cardiac Defibrillators
          • 5.3.1.1.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.1.1.5. Pacemakers
          • 5.3.1.1.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.1.1.6. Vascular Grafts
          • 5.3.1.1.6.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.1.1.7. Others
          • 5.3.1.1.7.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.2. Ophthalmology
      • 5.3.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.2.1.1. Synthetic Corneas
          • 5.3.2.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.2.1.2. Intraocular Lens
          • 5.3.2.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.2.1.3. Contact Lens
          • 5.3.2.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.2.1.4. Ocular Tissue Replacement
          • 5.3.2.1.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.2.1.5. Others
          • 5.3.2.1.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.3. Dental
      • 5.3.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.3.1.1. Tissue Regeneration Materials
          • 5.3.3.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.3.1.2. Dental Implants
          • 5.3.3.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.3.1.3. Bone Grafts & Substitutes
          • 5.3.3.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.3.1.4. Dental Membranes
          • 5.3.3.1.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.3.1.5. Others
          • 5.3.3.1.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.4. Orthopedic
      • 5.3.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.4.1.1. Joint Replacement biomaterials
          • 5.3.4.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.4.1.2. Orthobiologics
          • 5.3.4.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.4.1.3. Bioresorbable Tissue Fixation Products
          • 5.3.4.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.4.1.4. Visco supplementation
          • 5.3.4.1.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.4.1.5. Spine Biomaterial
          • 5.3.4.1.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.4.1.6. Others
          • 5.3.4.1.6.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.5. Wound Healing
      • 5.3.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.5.1.1. Fracture Healing Device
          • 5.3.5.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.5.1.2. Adhesion Barrier
          • 5.3.5.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.5.1.3. Skin Substitutes
          • 5.3.5.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.5.1.4. Internal Tissue Sealant
          • 5.3.5.1.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.5.1.5. Surgical Hemostats
          • 5.3.5.1.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.5.1.6. Others
          • 5.3.5.1.6.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.6. Tissue Engineering
      • 5.3.6.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.7. Plastic Surgery
      • 5.3.7.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.7.1.1. Facial Wrinkle Treatment
          • 5.3.7.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.7.1.2. Soft Tissue Fillers
          • 5.3.7.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.7.1.3. Craniofacial Surgery
          • 5.3.7.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.7.1.4. Bioengineered Skins
          • 5.3.7.1.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.7.1.5. Peripheral Nerve Repair
          • 5.3.7.1.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.7.1.6. Acellular Dermal Matrices
          • 5.3.7.1.6.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.7.1.7. Others
          • 5.3.7.1.7.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.8. Neurology
      • 5.3.8.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.8.1.1. Neural Stem Cell Encapsulation
          • 5.3.8.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.8.1.2. Shunting Systems
          • 5.3.8.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.8.1.3. Hydrogel Scaffold For CNS Repair
          • 5.3.8.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.8.1.4. Cortical Neural Prosthetics
          • 5.3.8.1.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
        • 5.3.8.1.5. Others
          • 5.3.8.1.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 5.3.9. Others
      • 5.3.9.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Marker Size, & Forecasts Trend Analysis, 2021 To 2033:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key Country Dynamics
      • 6.3.1.2. Competitive Scenario
      • 6.3.1.3. Regulatory Framework
      • 6.3.1.4. U.S. Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Canada Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Mexico Market Estimates And Forecasts 2021 To 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Competitive Scenario
      • 6.4.1.3. Regulatory Framework
      • 6.4.1.4. UK Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Germany Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.4.3. Spain
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Spain Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Denmark Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Sweden Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Norway Market Estimates And Forecasts 2021 To 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory Framework
      • 6.5.1.4. Japan Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. China Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. India Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.5.4. South Korea
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. South Korea Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Australia Market Estimates And Forecasts 2021 To 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory Framework
      • 6.6.1.4. Brazil Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Argentina Market Estimates And Forecasts 2021 To 2033 (USD Million)
  • 6.7. Middle East and Africa
    • 6.7.1. South Africa
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. South Africa Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Saudi Arabia Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. UAE Market Estimates And Forecasts 2021 To 2033 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Kuwait Market Estimates And Forecasts 2021 To 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Global Market Position Analysis
  • 7.3. Company /Competition Categorization
    • 7.3.1. Medtronic
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Evonik Industries AG
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Carpenter Technology Corporation
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Berkeley Advanced Biomaterials
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Invibio Ltd
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Zimmer Biomet Holdings, Inc.
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. BASF SE
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Covalon Technologies Ltd
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Stryker
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Johnson & Johnson
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Dentsply Sirona
      • 7.3.11.1. Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Product Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. CoorsTek Inc
      • 7.3.12.1. Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Product Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Corbion
      • 7.3.13.1. Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Product Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Regenity Biosciences
      • 7.3.14.1. Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Product Benchmarking
      • 7.3.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Biomaterials Market, Region, 2021 - 2033 (USD Million)
  • Table 3 North America Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 North America Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 5 U.S. Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 U.S. Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Canada Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 8 Canada Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 9 Europe Biomaterials Market, Region, 2021 - 2033 (USD Million)
  • Table 10 Europe Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 Europe Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 UK Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 13 UK Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 Germany Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 15 Germany Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 France Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 France Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 Italy Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 19 Italy Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Spain Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 21 Spain Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 22 Sweden Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 23 Sweden Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Norway Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 25 Norway Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 Denmark Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Denmark Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific Biomaterials Market, Region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 31 Japan Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 Japan Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 China Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 34 China Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 India Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 36 India Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 Australia Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 38 Australia Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 South Korea Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 40 South Korea Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Thailand Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 42 Thailand Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 43 Latin America Biomaterials Market, Region, 2021 - 2033 (USD Million)
  • Table 44 Latin America Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 45 Latin America Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 46 Brazil Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Brazil Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 48 Mexico Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 49 Mexico Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 50 Argentina Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Argentina Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 Middle East and Africa Biomaterials Market, Region, 2021 - 2033 (USD Million)
  • Table 53 Middle East and Africa Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 54 Middle East and Africa Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 South Africa Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 56 South Africa Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 59 UAE Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 60 UAE Biomaterials Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 Kuwait Biomaterials Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 Kuwait Biomaterials Market, By Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Market Research Approaches
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Biomaterials Market: Market Outlook
  • Fig. 6 Biomaterials Competitive Insights
  • Fig. 7 Parent Market Outlook
  • Fig. 8 Related/Ancillary Market Outlook
  • Fig. 9 Penetration And Growth Prospect Mapping
  • Fig. 10 Industry Value Chain Analysis
  • Fig. 11 Biomaterials Market Driver Impact
  • Fig. 12 Biomaterials Market Restraint Impact
  • Fig. 13 Biomaterials Market Strategic Initiatives Analysis
  • Fig. 14 Biomaterials Market: Product Movement Analysis
  • Fig. 15 Biomaterials Market: Product Outlook And Key Takeaways
  • Fig. 16 Metallic Market Estimates And Forecast, 2021 - 2033
  • Fig. 17 Natural Market Estimates And Forecast, 2021 - 2033
  • Fig. 18 Ceramics Market Estimates And Forecast, 2021 - 2033
  • Fig. 19 Polymers Market Estimates And Forecast, 2021 - 2033
  • Fig. 20 Biomaterials Market: Application Movement Analysis
  • Fig. 21 Biomaterials Market: Application Outlook And Key Takeaways
  • Fig. 22 Cardiovascular Market Estimates And Forecasts, 2021 - 2033
  • Fig. 23 Ophthalmology Market Estimates And Forecasts, 2021 - 2033
  • Fig. 24 Dental Market Estimates And Forecasts, 2021 - 2033
  • Fig. 25 Orthopedic Market Estimates And Forecasts, 2021 - 2033
  • Fig. 26 Wound Healing Market Estimates And Forecasts, 2021 - 2033
  • Fig. 27 Tissue Engineering Market Estimates And Forecasts, 2021 - 2033
  • Fig. 28 Plastic Surgery Market Estimates And Forecasts, 2021 - 2033
  • Fig. 29 Neurology Market Estimates And Forecasts, 2021 - 2033
  • Fig. 30 Others Market Estimates And Forecasts, 2021 - 2033
  • Fig. 31 Global Biomaterials Market: Regional Movement Analysis
  • Fig. 32 Global Biomaterials Market: Regional Outlook And Key Takeaways
  • Fig. 33 North America
  • Fig. 34 North America Market Estimates And Forecasts, 2021 - 2033
  • Fig. 35 U.S.
  • Fig. 36 U.S. Market Estimates And Forecasts, 2021 - 2033
  • Fig. 37 Canada
  • Fig. 38 Canada Market Estimates And Forecasts, 2021 - 2033
  • Fig. 39 Mexico
  • Fig. 40 Mexico Market Estimates And Forecasts, 2021 - 2033
  • Fig. 41 Europe
  • Fig. 42 Europe Market Estimates And Forecasts, 2021 - 2033
  • Fig. 43 UK
  • Fig. 44 UK Market Estimates And Forecasts, 2021 - 2033
  • Fig. 45 Germany
  • Fig. 46 Germany Market Estimates And Forecasts, 2021 - 2033
  • Fig. 47 France
  • Fig. 48 France Market Estimates And Forecasts, 2021 - 2033
  • Fig. 49 Italy
  • Fig. 50 Italy Market Estimates And Forecasts, 2021 - 2033
  • Fig. 51 Spain
  • Fig. 52 Spain Market Estimates And Forecasts, 2021 - 2033
  • Fig. 53 Denmark
  • Fig. 54 Denmark Market Estimates And Forecasts, 2021 - 2033
  • Fig. 55 Sweden
  • Fig. 56 Sweden Market Estimates And Forecasts, 2021 - 2033
  • Fig. 57 Norway
  • Fig. 58 Norway Market Estimates And Forecasts, 2021 - 2033
  • Fig. 59 Asia Pacific
  • Fig. 60 Asia Pacific Market Estimates And Forecasts, 2021 - 2033
  • Fig. 61 China
  • Fig. 62 China Market Estimates And Forecasts, 2021 - 2033
  • Fig. 63 Japan
  • Fig. 64 Japan Market Estimates And Forecasts, 2021 - 2033
  • Fig. 65 India
  • Fig. 66 India Market Estimates And Forecasts, 2021 - 2033
  • Fig. 67 Thailand
  • Fig. 68 Thailand Market Estimates And Forecasts, 2021 - 2033
  • Fig. 69 South Korea
  • Fig. 70 South Korea Market Estimates And Forecasts, 2021 - 2033
  • Fig. 71 Australia
  • Fig. 72 Australia Market Estimates And Forecasts, 2021 - 2033
  • Fig. 73 Latin America
  • Fig. 74 Latin America Market Estimates And Forecasts, 2021 - 2033
  • Fig. 75 Brazil
  • Fig. 76 Brazil Market Estimates And Forecasts, 2021 - 2033
  • Fig. 77 Argentina
  • Fig. 78 Argentina Market Estimates And Forecasts, 2021 - 2033
  • Fig. 79 Middle East And Africa
  • Fig. 80 Middle East And Africa Market Estimates And Forecasts, 2021 - 2033
  • Fig. 81 South Africa
  • Fig. 82 South Africa Market Estimates And Forecasts, 2021 - 2033
  • Fig. 83 Saudi Arabia
  • Fig. 84 Saudi Arabia Market Estimates And Forecasts, 2021 - 2033
  • Fig. 85 UAE
  • Fig. 86 UAE Market Estimates And Forecasts, 2021 - 2033
  • Fig. 87 Kuwait
  • Fig. 88 Kuwait Market Estimates And Forecasts, 2021 - 2033